Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
Myriad Genetics announced that management will participate in the BofA Securities 2026 Health Care Conference on May 13, 2026, engaging in 1-to-1 investor meetings. The company is also scheduled to attend the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026, featuring a fireside chat at 8:40 a.m. ET.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.